Keywords: biocryst, setback, bcx-34, trials, pharmaceuticals, reported, its

Biocryst Setback In BCX-34 Trials

Article | 02 October 1997

Print This

Biocryst Pharmaceuticals has reported that its topical cream formulationof BCX-34 has been unable to show superiority over placebo in interim ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in